ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: Growth hormone deficiency and other growth disorders

Society guideline links: Growth hormone deficiency and other growth disorders

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Turner syndrome" and "Society guideline links: Diagnosis and treatment of acromegaly".)

International

Growth Hormone Research Society (GRS): Diagnosis, genetics, and therapy of short stature in children – A international perspective (2019)

Endocrine Society (ES): Clinical practice guideline on hypothalamic-pituitary and growth disorders in survivors of childhood cancer (2018)

GRS: GH safety workshop position paper – A critical appraisal of recombinant human GH therapy in children and adults (2016)

GRS: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome (2013)

ES: Clinical practice guideline for the evaluation and treatment of adult growth hormone deficiency (2011)

GRS, International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), International Society for IGF Research, and Pituitary Society (PS): Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays (2011)

GRS, Lawson Wilkins Pediatric Endocrine Society (LWPES), and European Society for Paediatric Endocrinology (ESPE): Consensus statement on the diagnosis and treatment of children with idiopathic short stature (2008)

GRS, ESPE, LWPES, European Society of Endocrinology (ESE), Japan Endocrine Society (JES), and Endocrine Society of Australia (ESA): Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II (2007)

International Societies of Pediatric Endocrinology and GRS: A consensus statement on the management of the child born small for gestational age through to adulthood (2007)

Canada

Canadian Paediatric Society (CPS): Practice point on recognizing and addressing atypical growth (2023)

CPS: Position statement on promoting optimal monitoring of child growth in Canada – Using the new World Health Organization growth charts (2014)

United States

American College of Medical Genetics (ACMG): Practice resource for genetic evaluation of short stature, focused revision (2021)

ACMG: Practice guideline for genetic evaluation of short stature (2009)

American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE): Guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care (2019)

Pediatric Endocrine Society (PES): Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents – Growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency (2016)

Growth Hormone Research Society (GRS), Lawson Wilkins Pediatric Endocrine Society (LWPES), and European Society for Paediatric Endocrinology (ESPE): Consensus statement on the diagnosis and treatment of children with idiopathic short stature (2008)

GRS, ESPE, LWPES, European Society of Endocrinology (ESE), Japan Endocrine Society (JES), and Endocrine Society of Australia (ESA): Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II (2007)

Europe

Growth Hormone Research Society (GRS), Lawson Wilkins Pediatric Endocrine Society (LWPES), and European Society for Paediatric Endocrinology (ESPE): Consensus statement on the diagnosis and treatment of children with idiopathic short stature (2008)

GRS, ESPE, LWPES, European Society of Endocrinology (ESE), Japan Endocrine Society (JES), and Endocrine Society of Australia (ESA): Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II (2007)

United Kingdom

National Institute for Health and Care Excellence (NICE): Technology appraisal guidance on human growth hormone (somatropin) for the treatment of growth failure in children (2010, reviewed 2022)

British Society for Paediatric Endocrinology and Diabetes (BSPED): UK consensus national guidelines for sex hormone priming for growth hormone (GH) stimulation testing (2021)

BSPED: Position statement on choice of delivery device for growth hormone prescribing (2020)

NICE: Quality standard on faltering growth (2020)

BSPED, British Association for Paediatric Nephrology (BAPN) and Paediatric Renal Interest Nutrition Group (PRING): Clinical guideline for monitoring growth in children with chronic kidney disease (2019)

NICE: Guideline on faltering growth – Recognition and management of faltering growth in children (2017)

BSPED: Shared care guidelines – Paediatric use of recombinant human growth hormone (r-hGH, somatropin) (2012, reviewed 2015)

Australia–New Zealand

Endocrine Society of Australia (ESA): Position statement on growth hormone replacement of growth hormone deficiency in adults

Choosing Wisely Australia: Do not initiate gonadotropin-releasing hormone (GnRH) analogue treatment in children outside of central precocious puberty, for the target outcome of delaying puberty and improving final adult height (2017)

Choosing Wisely Australia: Do not rely solely on bone age measurement for assessing growth in young children with short stature under 2 years of age (2017)

Choosing Wisely Australia: Do not routinely prescribe aromatase inhibitors to promote growth in children with short stature (2017)

Choosing Wisely Australia: Do not routinely measure insulin-like growth factor binding protein 3 (IGFBP-3) for workup and diagnosis of childhood short stature (2017)

Growth Hormone Research Society (GRS), European Society for Paediatric Endocrinology (ESPE), Lawson Wilkins Pediatric Endocrine Society (LWPES), European Society of Endocrinology (ESE), Japan Endocrine Society (JES), and ESA: Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II (2007)

Japan

Growth Hormone Research Society (GRS), European Society for Paediatric Endocrinology (ESPE), Lawson Wilkins Pediatric Endocrine Society (LWPES), European Society of Endocrinology (ESE), Japan Endocrine Society (JES), and Endocrine Society of Australia (ESA): Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II (2007)

Topic 114455 Version 19.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟